Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.240
+0.190 (4.69%)
Jul 9, 2025, 4:00 PM - Market closed

Radiopharm Theranostics Market Cap

Radiopharm Theranostics has a market cap or net worth of $32.42 million as of July 9, 2025. Its market cap has increased by 158.55% in one year.

Market Cap
32.42M
Enterprise Value
7.85M
1-Year Change
158.55%
Ranking
Category
Stock Price
$4.24

Market Cap Chart

Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $32.42M, a decrease of -55.49%. That is a compound annual growth rate of -20.03%.

History

DateMarket Cap% Change
Jul 9, 202532.40M-0.56%
Dec 31, 202432.58M73.79%
Dec 29, 202318.75M-20.04%
Dec 30, 202223.45M-67.78%
Dec 31, 202172.76M-0.12%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 693.83B
Johnson & Johnson 373.59B
AbbVie 331.43B
Novo Nordisk 308.12B
UnitedHealth Group 275.51B
Novartis AG 240.05B
Abbott Laboratories 232.62B
AstraZeneca 216.19B
Market Cap Rankings